Free Public Brief · No Login Required

Weekly FDA Enforcement Pulse

A curated snapshot of national enforcement activity — OAI classifications, district intensity, and one live prospect from the Bureau483 pipeline. Updated every Monday.

Week of —

National Enforcement Snapshot

47
OAI Classifications This Week
12
Warning Letters Issued
Drugs
Hardest Hit Product Type
124d
National Median Lag
Source: FDLI, Oct 2025

District Heat Map

Low OAI
High OAI

OAI inspection volume by FDA district, trailing 7 days. District-level aggregates only — no facility names or FEI numbers.

Featured Facility Teaser

Top Ranked Prospect · Live Pipeline
Altaire Pharmaceuticals, Inc.
Critical Window
State
NY
Product Type
Drugs
Days Elapsed
138d
Window Status
Critical
21 CFR 211.192 21 CFR 211.100 21 CFR 211.68
Full pipeline access requires a territory license
View Available Territories

Weekly Enforcement Stat

FY2025 CDER warning letters increased 59% over FY2024 — the sharpest single-year jump since 2012.
Source: FDA CDER Office of Compliance · FY2025 enforcement data
Get the weekly pulse delivered to your inbox.
Every Monday morning — OAI classifications, district activity, and one featured facility from the active enforcement window. Free. No login required.
No spam. Unsubscribe anytime. bureau483.com/privacy

Bureau483 subscribers receive the full ranked prospect list every Monday morning. Territories are exclusive.

View Available Territories